Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.16 -0.13 (-0.33%)
As of: Sep 30, 2026 · 2:12 PM EDT

Harmony Biosciences Holdings (HRMY) Total Current Liabilities (2019 - 2026)

Updated

Harmony Biosciences Holdings' Total Current Liabilities was $234.07 million in Q2 2026, up 29.9% from $180.14 million a year earlier and up 7.7% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Harmony Biosciences Holdings came in at $252.13 million, up 44.0% from FY2024.

  • Total Current Liabilities has now increased for four consecutive years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $175.08 million in FY2024 (+6.9%), $163.78 million in FY2023 (+107.6%), $78.88 million in FY2022 (+46.7%) and $53.78 million in FY2021 (-60.0%).
  • Quarterly Total Current Liabilities has moved between $47.62 million (Q3 2021) and $252.13 million (Q4 2025) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for 18 straight quarters, with growth averaging 27.9% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2022 (growth of 125.4%); the worst was Q4 2021 (a decline of 60.0%).
  • Per Business Quant data, HRMY's Total Current Liabilities in the three quarters before Q2 2026 was $217.34 million (Q1 2026), $252.13 million (Q4 2025) and $223.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Harmony Biosciences Holdings 2.28 Bn -473.07 Mn 198.08 Mn 234.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 234.07 Mn
Mar 31, 2026 217.34 Mn
Dec 31, 2025 252.13 Mn
Sep 30, 2025 223.40 Mn
Jun 30, 2025 180.14 Mn
Mar 31, 2025 175.12 Mn
Dec 31, 2024 175.08 Mn
Sep 30, 2024 161.28 Mn
Jun 30, 2024 146.58 Mn
Mar 31, 2024 154.25 Mn
Dec 31, 2023 163.78 Mn
Sep 30, 2023 112.41 Mn
Jun 30, 2023 93.05 Mn
Mar 31, 2023 85.36 Mn
Dec 31, 2022 78.88 Mn
Sep 30, 2022 107.36 Mn
Jun 30, 2022 65.76 Mn
Mar 31, 2022 56.53 Mn
Dec 31, 2021 53.78 Mn
Sep 30, 2021 47.62 Mn
API Access

Harmony Biosciences Holdings Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=HRMY&period=max&api_key=YOUR_API_KEY